Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib vs Placebo in Advanced Hepatocellular Carcinoma
NCT01210495Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of axitinib in hepatocellular carcinoma (HCC), sponsored by Pfizer. Started Dec 2010; status: completed.
02
Drugs
axitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01210495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210495.